Murchinson, a Nano Dimension shareholder with 7.4% of shares, criticized the board's decision to pursue a transaction with Infinite Epigenetics. The firm called the deal a misallocation of resources that would dilute existing shareholders. Murchinson also noted the conference call offered no shareholder Q&A opportunity.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
NYC Comptroller Slams SpaceX Governance as Unprecedented